ArthroCare makes Fitzgerald permanent head
This article was originally published in Clinica
David Fitzgerald, who has been serving as interim president and CEO for minimally-invasive surgical technologies developer ArthroCare since February, has taken up the role on a permanent basis. Mr Fitzgerald joined ArthroCare's board of directors in 2003 – his career includes 25 years at Pfizer, of which the last 15 were spent as president and CEO of its Howmedica Orthopedics division. He took the helm of Austin, Texas-based ArthroCare after its previous president and CEO Michael Baker stepped down following an internal audit of the company which found evidence of improper business practices by its staff (www.clinica.co.uk, February 19 2009).